ECCO 2019 European Cancer Summit
Reaching the 70:35 Vision for cancer – 70% long term survival for all cancer patients across Europe by 2035 – requires breaking down the borders of cancer care: between countries, professions, sectors and stakeholders.
Join us to chart how to make that happen sooner, and be part of the border-breaking community in cancer care!
The ECCO 2019 European Cancer Summit will:
- Debate leading-edge ideas in achieving improvement in cancer care
- Determine consensus resolutions for improving health systems
- Decide on an action plan for the way forward to ensure ideas translate into policies that will impact daily clinical practice
Why should you attend?
- The Summit unites the multidisciplinary community
- Share knowledge and drive the debate on achieving improvement in cancer care
- Demand the changes required to improve patient outcomes
- Engage in resolution-forming to shape the EU cancer policy agenda
- Translating ideas into policies that will impact daily clinical practice
- Network with leaders from cancer health care, patient advocacy and stakeholder communities
- Represent your organisation’s voice to the change-making community of European cancer care
Who should attend?
Current and future leadership and officers from staff and professional levels of:
- Representatives of ECCO Member Societies
- Patient organisations including patient advocates
- Healthcare providers including hospitals, cancer centres and oncology departments
- Healthcare insurance providers and other payer organisations
- Education providers
- Commercial providers to the healthcare sector
- EU and national/regional government officials
- Public affairs professionals
- Elected policy makers in the healthcare sector
- Academic researchers
- Regulatory professionals
As with all ECCO events, a special feature is the collaboration between our different member societies and ECCO Patient Advisory Committee in producing high-quality, stimulating and illuminating sessions, and providing a platform for neglected aspects in the cancer policy debate to receive attention.
SAVE THE DATE FLYER